IDEXX Laboratories Analyst Ratings
BenzingaFeb 6 10:43 ET
Piper Sandler Downgrades Idexx to Neutral, Cites Macro Headwinds
Seeking AlphaJan 30 16:08 ET
IDEXX Laboratories Analyst Ratings
BenzingaJan 30 05:34 ET
IDEXX Laboratories Analyst Ratings
BenzingaJan 17 10:17 ET
Piper Sandler Maintains Overweight on IDEXX Laboratories, Raises Price Target to $525
BenzingaNov 6, 2023 10:19 ET
IDEXX Laboratories Analyst Ratings
BenzingaNov 6, 2023 10:18 ET
Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $592
BenzingaNov 2, 2023 11:21 ET
IDEXX Laboratories Analyst Ratings
BenzingaNov 2, 2023 11:20 ET
Stifel Maintains Hold on IDEXX Laboratories, Lowers Price Target to $460
BenzingaOct 30, 2023 11:10 ET
IDEXX Laboratories Analyst Ratings
BenzingaOct 30, 2023 11:09 ET
Stifel Maintains Hold on IDEXX Laboratories, Lowers Price Target to $500
BenzingaSep 15, 2023 08:51 ET
IDEXX Laboratories Analyst Ratings
BenzingaSep 15, 2023 08:50 ET
Morgan Stanley Maintains Overweight on IDEXX Laboratories, Raises Price Target to $600
BenzingaAug 3, 2023 10:48 ET
IDEXX Laboratories Analyst Ratings
BenzingaAug 3, 2023 10:47 ET
JP Morgan Maintains Overweight on IDEXX Laboratories, Raises Price Target to $600
BenzingaAug 2, 2023 13:20 ET
IDEXX Laboratories Analyst Ratings
BenzingaAug 2, 2023 13:19 ET
Atlantic Equities Reiterates Overweight on IDEXX Laboratories, Maintains $600 Price Target
BenzingaAug 2, 2023 06:26 ET
IDEXX Laboratories Analyst Ratings
BenzingaAug 2, 2023 06:25 ET
Atlantic Equities Reiterates Overweight on IDEXX Laboratories, Maintains $600 Price Target
BenzingaJun 7, 2023 04:30 ET
Atlantic Equities Reiterates Overweight on IDEXX Laboratories, Maintains $600 Price Target
BenzingaMay 3, 2023 05:47 ET
No Data
No Data